Cargando…

Innate Immune Response in SARS-CoV-2 Infection

An efficient host immune response is crucial in controlling viral infections. Despite most studies focused on the implication of T and B cell response in COVID-19 (Corona Virus Disease-19) patients or in their activation after vaccination against SARS-CoV-2, host innate immune response has raised ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiuma, Giovanna, Beltrami, Silvia, Bortolotti, Daria, Rizzo, Sabrina, Rizzo, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950297/ https://www.ncbi.nlm.nih.gov/pubmed/35336077 http://dx.doi.org/10.3390/microorganisms10030501

Ejemplares similares

SARS-CoV-2 Systemic Effects: New Clues
por: Beltrami, Silvia, et al.
Publicado: (2023)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection
por: Bortolotti, Daria, et al.
Publicado: (2021)

Gestational Viral Infections: Role of Host Immune System
por: Beltrami, Silvia, et al.
Publicado: (2023)

Effect of SARS-CoV-2 infection in pregnancy on CD147, ACE2 and HLA-G expression
por: Schiuma, Giovanna, et al.
Publicado: (2023)

Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma
por: Bortolotti, Daria, et al.
Publicado: (2022)

SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020)

SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway
por: Bortolotti, Daria, et al.
Publicado: (2020)

Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity
por: Bortolotti, Daria, et al.
Publicado: (2022)

Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion
por: Bortolotti, Daria, et al.
Publicado: (2021)

Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
por: Ricci, Daniela, et al.
Publicado: (2021)

Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS
por: Pi, Keng-Shuo, et al.
Publicado: (2022)

NOD2-dependent BCG-induced trained immunity: A way to regulate innate responses to SARS-CoV2?
por: Wannigama, Dhammika Leshan, et al.
Publicado: (2020)

Role of the early secretory pathway in SARS-CoV-2 infection
por: Sicari, Daria, et al.
Publicado: (2020)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma?
por: Hajighasemi, Saeideh, et al.
Publicado: (2023)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges
por: Wu, Tangchun
Publicado: (2020)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020)

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
por: Marchesi, Elena, et al.
Publicado: (2023)

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
por: Netea, Mihai G., et al.
Publicado: (2020)

HLA-G Molecules in Autoimmune Diseases and Infections
por: Rizzo, Roberta, et al.
Publicado: (2014)

Cross-reactive memory T cells and herd immunity to SARS-CoV-2
por: Lipsitch, Marc, et al.
Publicado: (2020)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

An Update on Innate Immune Responses during SARS-CoV-2 Infection
por: Zhang, Yu, et al.
Publicado: (2021)

SARS-CoV-2 infections in children: Understanding diverse outcomes
por: Brodin, Petter
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

Stillbirth and fetal capillary infection by SARS-CoV-2
por: di Gioia, Cira, et al.
Publicado: (2022)

The Many Faces of Innate Immunity in SARS-CoV-2 Infection
por: Hanan, Nicholas, et al.
Publicado: (2021)

Innate immunity to SARS-CoV-2 infection: a review
por: Silva, Marcos Jessé Abrahão, et al.
Publicado: (2022)

Case report: Tissue positivity for SARS-CoV-2 in a preterm born infant death of thrombosis: possible intrauterine transmission
por: Greco, Salvatore, et al.
Publicado: (2023)

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
por: Cao, Qing, et al.
Publicado: (2020)

Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome
por: Aguirre García, María Magdalena, et al.
Publicado: (2021)

Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
por: Guo, Meng, et al.
Publicado: (2021)

Postacute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked
por: Koutalos, Antonios A., et al.
Publicado: (2022)

Ozonated Oil in Liposome Eyedrops Reduces the Formation of Biofilm, Selection of Antibiotic-Resistant Bacteria, and Adhesion of Bacteria to Human Corneal Cells
por: Gentili, Valentina, et al.
Publicado: (2023)

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5csivk4sl65stg74irjcg0ifd